دوره 19، شماره 5 - ( 3-1400 )                   جلد 19 شماره 5 صفحات 303-303 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akhlaghi M, Ansari K, Zare Zadeh M, Haghirosadat BF, Ebrahimpour M. P-136 Evaluation and comparison of miRNA-15a loaded liposome and free miRNA-15a in PC3 prostate cancer cell line. IJRM 2021; 19 (5) :303-303
URL: http://ijrm.ir/article-1-3046-fa.html
P-136 Evaluation and comparison of miRNA-15a loaded liposome and free miRNA-15a in PC3 prostate cancer cell line. International Journal of Reproductive BioMedicine. 1400; 19 (5) :303-303

URL: http://ijrm.ir/article-1-3046-fa.html


چکیده:   (263 مشاهده)
Background: Prostate cancer is one of the most common cancers in men. mircroRNA-15a is categorized as the tumor suppressor miRNAs, but its instability in plasma and low cellular uptake highlight the essential need for an appropriate carrier to deliver this gene to the target tissue.
Objective: The aim of this study was to compare the viability percentage of prostate cancer cells treated with liposomal system containing miRNA-15a vs. free form of miRNA-15a.
Materials and Methods: In this study, miRNA-15a was synthesized on an optimized liposomal system with ratio N / p = 50.1 by incubation at 25oC for 30 minutes. Then prostate cancer cell line (PC3) were treated with non-loaded liposome, free miRNA-15a and miRNa15-a loaded liposome and cell viability was calculated by MTT assay.
Results: The MTT results showed that the viability percentage of PC3 cells treated with none loaded liposome, free miRNA-15a and miRNA-15a were 100%, 97%, and 90% respectively.
Conclusion: According to the results of MTT assay, by loading miRNA-15a on the optimized liposome, its stability and cellular uptake increased and the viability of cancer cells decreased.
نوع مطالعه: Congress Abstract |

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به International Journal of Reproductive BioMedicine می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb